Home » Topics » Regulatory » Patents

Patents
RSS

New carbapenems in development at Takeda

Jan. 8, 1998

COX-2 inhibitors under study at Abbott

Jan. 8, 1998

Protein farnesyltransferase inhibitors disclosed by Schering-Plough

Jan. 8, 1998

Bristol-Myers Squibb prepares melatonergic agents

Jan. 7, 1998

SKB reports prodrugs of 5-HT2C receptor antagonists

Jan. 7, 1998

More on peptidomimetic protein farnesyltransferase inhibitors from Merck & Co.

Jan. 7, 1998

Warner-Lambert develops new ET antagonists

Jan. 7, 1998

Fujisawa isolates new agent for influenza

Jan. 7, 1998

Taiho describes compounds for post-PTCA restenosis

Jan. 7, 1998

Tanabe Seiyaku patents new ACAT and lipid peroxidation inhibitors

Jan. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...